Han, Bing
Zhen, Fang
Zheng, Xiu-Shuang
Hu, Jing
Chen, Xue-Song
Funding for this research was provided by:
National Natural Science Foundation of China (81972162, 81573001)
Natural Science Fund for Outstanding Youth of Heilongjiang Province (YQ2019H026)
Postdoctoral Scientific Research Staring Fund of Heilongjiang Province (LBH-Q19042)
Major Program of Haiyan Fund of Harbin Medical University Cancer Hospital (JJZD2019-04)
Article History
Received: 9 October 2021
Accepted: 8 March 2022
First Online: 21 March 2022
Declarations
:
: Since all the data were retrieved from the online databases, we assumed that all written informed consent had been already obtained. Breast cancer tissues were taken from patients undergoing surgical resection at the Harbin Medical University Cancer Hospital (Harbin, China). All work was approved by the Ethics Committee of Harbin Medical University. All experimental procedures comply with the experimental management regulations of the State Council of the People's Republic of China, and strictly follow China's GCP, the "Declaration of Helsinki" and relevant Chinese laws and regulations. All experimental protocols were approved by the Ethics Licensing Committee of Harbin Medical University. All methods are carried out in accordance with relevant guidelines and regulations. All patients signed the "Informed Consent for Secondary Use of Pathological Data/Biological Specimens". The patient's identity is coded with numeric keys. The results of this study have no effect on their treatment or the treatment of other patients.
: We have obtained consents to publish from all the participants of this study.
: The authors declare that they have no competing interests.